MRCE Administrative Core
MRCE 行政核心
基本信息
- 批准号:7641628
- 负责人:
- 金额:$ 55.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AccountabilityAdvisory CommitteesAreaBiotechnologyBioterrorismChairpersonChildhoodClassClinicalCommunicable DiseasesConsultCore FacilityEducational workshopEmergency SituationEmerging Communicable DiseasesEnsureEthnic groupEventFacultyFloorFosteringFundingGoalsHousingIndividualInstitutionLettersMedicineMethodologyMicrobiologyMissionMissouriMolecularOccupational activity of managing financesOrganizational ModelsPediatric ResearchPliabilityPostdoctoral FellowProgram DevelopmentProgram Research Project GrantsReagentResearchResearch InstituteResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingResourcesScienceStagingStrategic PlanningTrainingUnited States National Institutes of HealthUniversitiesVirginiaWashingtonWomanWorkauthoritybasebiodefensecareerdayinnovationinterestmedical schoolsmemberprogramsracial and ethnicresponsesymposium
项目摘要
The organizational model for the MRCE is shown in the figure below. The MRCE currently
encompasses five major institutional partners, Case Western Reserve University, the Midwest Research
Institute, St. Louis University School of Medicine, the University of Missouri, and Washington University School
of Medicine. These institutions will house the Core Facilities and be primarily responsible for the research and
training missions of the MRCE. In the planning stages of the MRCE, partner status was offered to all the
leading academic centers within Region VII. Some of these institutions elected to develop their own consortia
and produce separate RCE or RCE planning applications. However, to best fulfill its mission of fostering
research and training in biodefense and emerging infectious diseases within all of Region VII, the MRCE will
remain open to the addition of interested institutions from the four State area or any geographically proximate
region not served by a RCE. These institutions will have the opportunity to become full institutional partners in
the MRCEmthis status will allow them to house core facilities, to apply for MRCE research support, and to fully
participate in the governance of the MRCE. Individual investigators from any institution or biotechnology
company within Region VII that have NIH or other governmental support to work on class A-C agents will be
eligible for MRCE membership. This will give them the right to access MRCE Core Facilities and apply for
MRCE research support.
The Administrative Core of the MRCE will be located within the Division of Infectious Diseases in the
Department of Medicine at Washington University School of Medicine. The line of accountability regarding the
financial management of the Research Core Facilities, Research Projects Programs, Career Develcpment
Programs, and Emergency Response Plan proceeds through the Administrative Core. Authority for the
Administrative Core proceeds through the Chairman of the Department of Medicine (Dr. Kenneth Polonsky),
and the Dean of the Medical School (Dr. William Peck, see letter of commitment). The Administrative Core
offices will be located in space provided by the Department of Medicine at Washington University School of
Medicine on the 7t"floor of the McDonnell Sciences Pediatric Research Building. On adjacent floors are the
Division of Pediatric Infectious Diseases, and the Department of Molecular Microbiology. The day to day
administration of the Center will be carried by the Director; in his absence, Dr. Virginia Miller will serve as
Acting-Director. The Director will consult on a regular basis with the co-Directors, Dr. Miller, Dr. Belshe, and
Dr. Kazura. The Director will be advised by the Executive Committee and the Advisory Committees.
MRCE的组织模型如下图所示。目前,MRCE
包括五个主要机构合作伙伴:凯斯西储大学、中西部研究中心
研究所、圣路易斯大学医学院、密苏里大学和华盛顿大学学院
医学。这些机构将拥有核心设施并主要负责研究和
MRCE 的培训任务。在 MRCE 的规划阶段,所有合作伙伴都获得了合作伙伴地位
第七区领先的学术中心。其中一些机构选择发展自己的联盟
并生成单独的 RCE 或 RCE 规划申请。然而,为了最好地履行其培育的使命
在整个第七区的生物防御和新出现的传染病方面进行研究和培训,MRCE 将
仍然欢迎来自四个州地区或任何地理位置邻近的感兴趣的机构加入
不受 RCE 服务的区域。这些机构将有机会成为全面的机构合作伙伴
MRCEm 这一地位将使他们能够拥有核心设施、申请 MRCE 研究支持,并充分
参与 MRCE 的治理。来自任何机构或生物技术的个人研究人员
第七区内获得 NIH 或其他政府支持从事 A-C 类药物研究的公司将
有资格成为 MRCE 会员。这将使他们有权使用 MRCE 核心设施并申请
MRCE 研究支持。
MRCE 的行政核心将设在传染病科内
华盛顿大学医学院医学系。有关的责任范围
研究核心设施、研究项目计划、职业发展的财务管理
计划和应急响应计划通过行政核心进行。当局
行政核心通过医学系主任(肯尼思·波隆斯基博士)进行,
和医学院院长(William Peck 博士,见承诺书)。行政核心
办公室将设在华盛顿大学医学院医学系提供的空间内
医学中心位于麦克唐纳科学儿科研究大楼 7 楼。相邻楼层是
儿科传染病科和分子微生物学系。日复一日
中心的行政管理将由主任负责;在他缺席的情况下,弗吉尼亚·米勒博士将担任
代理导演。主任将定期与联合主任 Miller 博士、Belshe 博士和
卡祖拉博士。执行委员会和咨询委员会将向主任提供建议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAMUEL L. STANLEY其他文献
SAMUEL L. STANLEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAMUEL L. STANLEY', 18)}}的其他基金
An Animal Biosafety Level 3 Laboratory for Stony Brook University
石溪大学动物生物安全三级实验室
- 批准号:
7872073 - 财政年份:2010
- 资助金额:
$ 55.86万 - 项目类别:
MRCE for Biodefense and Emerging Infectious Diseases (Development Projects)
生物防御和新发传染病 MRCE(开发项目)
- 批准号:
7641692 - 财政年份:2008
- 资助金额:
$ 55.86万 - 项目类别:
MRCE for Biodefense and Emerging Infectious Diseases
生物防御和新发传染病的 MRCE
- 批准号:
7207962 - 财政年份:2003
- 资助金额:
$ 55.86万 - 项目类别:
MRCE for Biodefense and Emerging Infectious Diseases
生物防御和新发传染病的 MRCE
- 批准号:
6908968 - 财政年份:2003
- 资助金额:
$ 55.86万 - 项目类别:
MRCE for Biodefense and Emerging Infectious Diseases
生物防御和新发传染病的 MRCE
- 批准号:
7594903 - 财政年份:2003
- 资助金额:
$ 55.86万 - 项目类别:
MRCE for Biodefense and Emerging Infectious Diseases
生物防御和新发传染病的 MRCE
- 批准号:
7020077 - 财政年份:2003
- 资助金额:
$ 55.86万 - 项目类别:
MRCE for Biodefense and Emerging Infectious Diseases
生物防御和新发传染病的 MRCE
- 批准号:
6698909 - 财政年份:2003
- 资助金额:
$ 55.86万 - 项目类别:
MRCE for Biodefense and Emerging Infectious Diseases
生物防御和新发传染病的 MRCE
- 批准号:
6797835 - 财政年份:2003
- 资助金额:
$ 55.86万 - 项目类别:
相似海外基金
Achieving Maternal Equity and Transforming Health through Implementation Science and Training (AMETHIST@Penn)
通过实施科学和培训实现孕产妇公平并改变健康状况 (AMETHIST@Penn)
- 批准号:
10748593 - 财政年份:2023
- 资助金额:
$ 55.86万 - 项目类别:
Immune determinants of pediatric HIV/SIV reservoir establishment and maintenance
儿科 HIV/SIV 病毒库建立和维持的免疫决定因素
- 批准号:
10701468 - 财政年份:2023
- 资助金额:
$ 55.86万 - 项目类别:
Intervention Methods: Provision and Connection through Technology (IMPACT)
干预方法:通过技术提供和连接(IMPACT)
- 批准号:
10580755 - 财政年份:2022
- 资助金额:
$ 55.86万 - 项目类别:
Pediatric Research Optimizing Methods in Stakeholder Engagement (PROMISE)
儿科研究优化利益相关者参与的方法(PROMISE)
- 批准号:
10580764 - 财政年份:2022
- 资助金额:
$ 55.86万 - 项目类别: